1. Zhan HQ, Zhang X, Chen XL, Cheng L, Wang X. Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives. J Nanobiotechnology, 2024 Jan 3;22(1):9.
2. Wang K, Zhan HQ (Co-first author), Hu Y, Yuan ZY, Yang JF, Yang DS, Tao LS, Xu T. The role of interleukin-20 in liver disease: Functions, Mechanisms and Clinical applications. Heliyon, 2024 April 17: e29853.
3. Liu C, Yuan ZY, Zhang XX, Chang JJ, Yang Y, Sun SJ, Du Y, Zhan HQ (Corresponding author). Novel molecular classification and prognosis of papillary renal cell carcinoma based on a large-scale CRISPR-Cas9 screening and machine learning. Heliyon, 2023 Dec 3;10(1):e23184.
4. Wang P, Liang T, Zhan H (Co-first author), Zhu M, Wu M, Qian L, Zhou Y, Ni F. Unique metabolism and protein expression signature in human decidual NK cells. Front Immunol. 2023, Mar 3;14:1136652.
5. Chen Y, Wu Y, Fang L, Zhao H, Xu S, Shuai Z, Yu H, Cai G, Zhan HQ (Co-corresponding author), Pan F. METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis. Clin Immunol, 2023 Nov 5:257:109838.
6. Zhan HQ, Zhang XX, Qin R, Fei J, Dong GY, Hao JH. Application of integrated problem-based learning combined with lecture-based classroom teaching in undergraduate medical education: An effective teaching model in a Medical School in China. Medicine (Baltimore), 2023 Aug 25;102(34):e34792.
7. Zhan HQ, Qin R, Li YL, Liu MM, Gan L. TFEB promotes BCL-2 expression by upregulating its promoter activity in the t(6;11) translocation renal cell carcinomas. Am J Transl Res, 2021 Aug 15;13(8):8804-8818.
8. Zhan HQ, Najmi M, Lin K, Aluri S, Fiser A, Goldman ID, Zhao R. A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation. J Biol Chem, 2020, Nov 13; 295 (46):15650-15661.
9. Zhan HQ, Li ST, Shu Y, Liu MM, Qin R, Li YL, Gan L. Alpha gene upregulates TFEB expression in renal cell carcinoma with t(6;11) translocation, which promotes cell canceration. Int J Oncol, 2018 Mar;52(3):933-944.
10. Liu MM, Li ST, Shu Y, Zhan HQ (Corresponding author). Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials. PLoS One, 2017 Jun 2;12(6):e0178870.
11. Zhan HQ, Hong Chen, Wang CF, Zhu XZ. A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic feature. Hum Pathol, 2015 Mar;46(3):476-481.
12. Zhan HQ, Li XQ, Zhu XZ, Lu HF, Zhou XY, Chen Y. Expression of follicular helper T-cell markers in nodal peripheral T-cell lymphomas: a tissue microarray analysis of 162 cases. J Clin Pathol, 2011 Apr; 64(4)319-324.
13. Zhan HQ, Wang CF, Zhu XZ, Xu XL. Renal Cell Carcinoma With t(6;11) Translocation: A Patient Case With a Novel Alpha-TFEB Fusion Point. J Clin Oncol, 2010 Dec;28(34): e709-713.
14. Zhan HQ, Li XQ, Zhu XZ, Guo Y, Lu HF, Li F. Concurrent occurrence of nodular lymphocyte predominant Hodgkin lymphoma and Kaposi sarcoma in lymph nodes: a first case report. J Clin Pathol, 2010 Aug;63(8):756-758.
15. Ding C, Liu J, Zhang J, Wan Y, Hu L, Charwudzi A, Zhan H, Meng Y, Zheng H, Wang H, Wang Y, Gao L, Hu X, Li J, Xiong S. Tumor Endothelial Marker 8 Promotes Proliferation and Metastasis via the Wnt/β-Catenin Signaling Pathway in Lung Adenocarcinoma. Front Oncol. 2021 Oct 14;11:712371.
16. Li M, Fang L, Kwantwi LB, He G, Luo W, Yang L, Huang Y, Yin S, Cai Y, Ma W, Zhan H, Tong Z, Zhang L, Liang C, Yin Y. N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8. Med Oncol. 2021 Sep 14;38(10):127.
17. Tu Z, Zhang S, Zhou G, Zhou L, Xiang Q, Chen Q, Zhao P, Zhan H, Zhou H, Sun L. LMO4 is a disease-provocative tranion coregulator activated by IL-23 in psoriatic keratinocytes. J Invest Dermatol. 2018 May;138(5):1078-1087.
18. Hou W, Xu L, Zhan H, Wang H, Xu M, Yu Y. Computed Tomography and Magnetic Resonance Imaging Characteristics of Peripheral Primitive Neuroectodermal Tumor: A Retrospective Analysis of 16 Cases. J Comput Assist Tomogr, 2017 Mar/Apr;41(2):224-230.
19. Zhu X, Meng Z, Chen Z, Wang K, Yu B, Zhan H, Liu L. Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intensity focused ultrasound therapy: a case report and review of the literature. Pancreas, 2011 Oct;40(7):1160-1162.
20. Ye Y, Shi Y, Zhou Y, Du C, Wang C, Zhan H, Zheng B, Cao X, Sun MH, Fu H. The Fibroblast Growth Factor Receptor-4 Arg388 Allele Is Associated with Gastric Cancer Progression. Ann Surg Oncol, 2010 Dec;17(12):3354-3361.
21. 詹鹤琴,常佳俊,袁瞻远等. 透明细胞肾细胞癌组织及四种不同肾细胞癌细胞株中EIF3B 的表达及意义. 临床与实验病理学杂志, 2022 Dec;38(12):1414-1420.
22. 詹鹤琴,虞红珍,秦蓉等. 创新理念下病理学专硕临床实践与科研创新能力的培养. 安徽医专学报, 2023,Oct 26; 22(5):95-97.
23. 詹鹤琴,秦蓉,李延莉. 多元化教学模式在留学生病理学教学中的应用—PBL、CBL及与传统教学法相结合. 合肥师范学院学报, 2020,38(3):57-60.
24. 刘蒙蒙,詹鹤琴(通讯作者),李延莉等. 弥漫大B细胞淋巴瘤中LMO4的表达及意义. 临床与实验病理学杂志,2019,35(9):1028-1032.
25. 舒炎,詹鹤琴(通讯作者),刘蒙蒙等. 弥漫大B细胞淋巴瘤中SEL1L、BCL-2的表达及意义. 临床与实验病理学杂志, 2018,34(2) : 153-157.
26. 李舒婷,詹鹤琴(通讯作者),舒炎等. siRNA抑制syk基因对外周T细胞淋巴瘤细胞增殖与凋亡的影响. 安徽医科大学学报, 2017,52(5): 628-633.
27. 詹鹤琴,袁毅,秦蓉. t (6;11)染色体易位肾细胞癌中Alpha基因片段的克隆及启动子活性分析. 中国肿瘤临床, 2014,41(15):951-956.
28. 詹鹤琴,朱雄增. 非特指性外周T细胞淋巴瘤中EBER、LMP1的表达及与预后的关系. 临床与实验病理学杂志, 2014,30(8):835-839.
29. 代群,詹鹤琴(通讯作者),曹立宇等. Syk、PI3K、Akt在外周T细胞淋巴瘤中的表达及其意义. 安徽医科大学学报, 2014,49(8):1141-1144.
30. 詹鹤琴,曹立宇,李昊等. 浅谈数字化虚拟切片在病理学实验教学中的应用. 安徽卫生职业技术学院学报, 2012,11(2):84-85.
31. 詹鹤琴, 朱雄增, 李小秋等. 滤泡变型外周T细胞淋巴瘤临床病理学及遗传学分析. 中华病理学杂志, 2011,40(1):32-36.
32. 詹鹤琴, 李小秋, 朱雄增. 非特殊型外周T细胞淋巴瘤的研究进展. 中华病理学杂志, 2010,39(5):353-356.
33. 詹鹤琴, 张洪福, 曹立宇. SEL1L蛋白、smad4蛋白在食管癌中的表达及其意义. 实用全科医学, 2007,10 (5) 849-850.
34. 詹鹤琴, 张洪福, 曹立宇等. 食管鳞状细胞癌中SEL1L蛋白的表达. 安徽医科大学学报, 2006,41(2)140-142.
35. 詹鹤琴, 张洪福. 胰腺浆液性微囊型腺瘤1例. 临床与实验病理学杂志, 2005 Aug;20(4) 507-508.